Evidence for a new fumarate hydratase gene mutation in a unilateral type 2 segmental leiomyomatosis

Dermatology

Volumn 221, Issue 2, 2010, Pages 149-153

  Parmentier, Laurent ^a   Tomlinson, Ian ^b   Happle, Rudolf ^c   Borradori, Luca ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Fumarate hydratase; Leiomyomatosis; Mosaicism

Indexed keywords

FUMARATE HYDRATASE; GENOMIC DNA;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; LEUKOCYTE; MALE; MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATA SYNDROME; PHENOTYPE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN TUMOR; UTERUS MYOMA;

ADULT; FUMARATE HYDRATASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LASER THERAPY; LEIOMYOMATOSIS; MALE; SEQUENCE DELETION; SKIN NEOPLASMS; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 77956339887     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315068     Document Type: Article

References (25)

1. Reed WB, Walker R, Horowitz R: Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 1973; 53: 409-416.
2. Tomlinson IP, Alam NA, Rowan AJ, et al: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002; 30: 406-410.
3. Alam NA, Rowan AJ, Wortham NC, et al: Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003; 12: 1241-1252.
4. Toro JR, Nickerson ML, Wei MH, et al: Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003; 73: 95-106.
5. Bayley JP, Launonen V, Tomlinson IPM: The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 2008; 9: 20.
6. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA: A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003; 3: 193-202.
7. Raimundo N, Ahtinen J, Fumí K, et al: Differential metabolic consequences of fumarate hydratase and respiratory chain defects. Biochim Biophys Acta 2008; 1782: 287-294.
8. Happle R: Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet 1996; 66: 241-242.
9. König A, Happle R: Two cases of type 2 segmental manifestation in a family with cutaneous leiomyomatosis. Eur J Dermatol 2000; 10: 590-592.
10. König A, Happle R: Type 2 segmental cutaneous leiomyomatosis. Acta Derm Venereol 2001; 81: 383.
11. Tsoitis G, Kanitakis J, Papadimitriou C, et al: Cutaneous leiomyomatosis with type 2 segmental involvement. J Dermatol 2001; 28: 251-255.
12. Ritzmann S, Hanneken S, Neumann NJ, et al: Type 2 segmental manifestation of cutaneous leiomyomatosis in four unrelated women with additional uterine leiomyomas (Reed's syndrome). Dermatology 2006; 212: 84-87.
13. Poblete-Gutiérrez P, Wiederholt T, König A, et al: Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 2004; 114: 1467-1474.
14. Badeloe S, Frank J: Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis. Eur J Dermatol 2009; 19: 545-551.
15. Matyakhina L, Freedman RJ, Bourdeau I, et al: Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab 2005; 90: 3773-3779.
16. Badeloe S, van Geel M, van Steensel MA, et al: Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol 2006; 15: 735-741.
17. Itin PH, Büchner SA, Happle R: Segmental manifestation of Darier disease. What is the genetic background in type 1 and type 2 mosaic phenotypes? Dermatology 2000; 200: 254-257.
18. König A, Hörster S, Vakilzadeh F, Happle R: Type 2 segmental manifestation of Hailey- Hailey disease: poor therapeutic response to dermabrasion is due to severe involvement of adnexal structures. Eur J Dermatol 2000; 10: 265-268.
19. Flórez A, Peteiro C, Sánchez-Aguilar D, et al: Three cases of type 2 segmental manifestation of multiple glomus tumors: association with linear multiple trichilemmal cysts in a patient. Dermatology 2000; 200: 75-77.
20. Pena-Penabad C, García-Silva J, del Pozo J, et al: Two cases of segmental multiple glomangiomas in a family: type 1 or type 2 segmental manifestation? Dermatology 2000; 201: 65-67.
21. Allombert-Blaise CJ, Batard ML, Ségard M, et al: Type 2 segmental manifestation of congenital multiple glomangiomas. Dermatology 2003; 206: 321-325.
22. Murata Y, Kumano K, Takai T: Type 2 segmental manifestation of disseminated superficial porokeratosis showing a systematized pattern of involvement and pronounced cancer proneness. Eur J Dermatol 2001; 11: 191-194.
23. Happle R: Type 2 segmental trichoepitheliomatosis: a genetic concept that may explain congenital multiple trichoepitheliomas in the lines of Blaschko. Pediatr Dermatol 2007; 24: 448-449.
24. Happle R, Fleiner J, Loskamp U: Kerinokeratosis papulosa with a type 2 segmental manifestation. J Am Acad Dermatol 2004; 50(5 suppl):S84-S85.
25. Ehrig T, Cockerell CJ: Buschke-Ollendorff syndrome: report of a case and interpretation of the clinical phenotype as a type 2 segmental manifestation of an autosomal dominant skin disease. J Am Acad Dermatol 2003; 49: 1163-1166.